Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
Do you prefer a dual-monitor setup for your home PC, work PC, or both? You're not imagining the advantages of using more than one monitor. Dell reviewed multiple studies (including its own study) and ...
This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes ...
is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...
BD (Becton, Dickinson and Company) has launched a new medical device designed to give clinicians continuous, noninvasive visibility into patients’ blood pressure. Dubbed the HemoSphere Stream Module, ...
Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...
Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest ...
Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as ...
Forbes contributors publish independent expert analyses and insights. I’m a founder, writer and lecturer focusing on VC funds. This voice experience is generated by AI. Learn more. This voice ...
The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...
Management of gestational diabetes can be more efficient with the use continuous glucose monitoring (CGM), according to new research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results